MATULANE Drug Patent Profile
✉ Email this page to a colleague
When do Matulane patents expire, and when can generic versions of Matulane launch?
Matulane is a drug marketed by Leadiant Biosci Inc and is included in one NDA.
The generic ingredient in MATULANE is procarbazine hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the procarbazine hydrochloride profile page.
Summary for MATULANE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 107 |
Clinical Trials: | 6 |
Patent Applications: | 4,431 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MATULANE |
What excipients (inactive ingredients) are in MATULANE? | MATULANE excipients list |
DailyMed Link: | MATULANE at DailyMed |
Recent Clinical Trials for MATULANE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Emmes Company, LLC | Phase 2 |
AIDS Malignancy Consortium | Phase 2 |
The EMMES Corporation | Phase 2 |
Pharmacology for MATULANE
Drug Class | Alkylating Drug |
Mechanism of Action | Alkylating Activity |
Anatomical Therapeutic Chemical (ATC) Classes for MATULANE
US Patents and Regulatory Information for MATULANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leadiant Biosci Inc | MATULANE | procarbazine hydrochloride | CAPSULE;ORAL | 016785-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MATULANE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leadiant Biosci Inc | MATULANE | procarbazine hydrochloride | CAPSULE;ORAL | 016785-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MATULANE
See the table below for patents covering MATULANE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 354653 | ⤷ Try a Trial | |
Belgium | 618638 | ⤷ Try a Trial | |
African Intellectual Property Organization (OAPI) | 1833 | ⤷ Try a Trial | |
United Kingdom | 968460 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |